Shandong Sino-Agri United Biotechnology Co Ltd
Shandong Sino-Agri United Biotechnology Co Ltd is a Chinese company engaged in the production and sale of agricultural chemicals, primarily serving the agricultural sector in China.
Business. Shandong Sino-Agri United Biotechnology Co Ltd (003042.SZ) is a Chinese company operating in the agricultural chemicals industry within the broader chemicals sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Shandong Sino-Agri United Biotechnology Co Ltd (003042.SZ) has been formally classified within the Chemicals activity and Basic Materials economic sector, marking a significant structural update to its corporate profile. This taxonomy shift, identified as a medium-severity change, clarifies the company's operational positioning within the broader industrial landscape, moving from an undefined status to a specific sectoral alignment. Concurrently, the company’s risk assessment framework has been initialized with two new key metrics. Dilution risk is now rated as low, indicating a stable capital structure with minimal threat of share value erosion from new issuances. This assessment provides investors with a clearer baseline for evaluating equity stability, a critical factor for long-term holding strategies. In contrast, liquidity risk has been established at a medium level. This designation suggests that while the company maintains operational viability, there may be moderate constraints on the ease of trading its shares or accessing immediate cash resources. This medium-severity signal warrants attention for traders and liquidity-focused investors who prioritize ease of entry and exit. These updates collectively enhance the transparency of Shandong Sino-Agri United’s financial and operational profile. By defining its sectoral identity and quantifying key risks such as dilution and liquidity, the company offers a more robust foundation for fundamental analysis, despite the current absence of analyst coverage or index membership data in the available records.
Signals & dispatch
Composite-score breakdown
Synthesis
Shandong Sino-Agri United Biotechnology Co Ltd (003042.SZ) is a Chinese company operating in the agricultural chemicals industry within the broader chemicals sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Shandong Sino-Agri United Biotechnology Co Ltd has a debt-to-equity ratio of 0.81, indicating a moderate level of leverage, while its current ratio of 0.84 suggests potential liquidity constraints, as current assets fall short of current liabilities. The company reported negative operating cash flow of -71.57 million CNY, which, combined with a net cash position that is negative after subtracting total debt, signals liquidity risk.
Profitability metrics are weak, with a return on equity of -0.76% and a return on assets of -0.29%, both significantly below the industry median for Agricultural Chemicals. The company reported a net loss of 11.04 million CNY and an operating loss of 3.11 million CNY, indicating a failure to generate positive returns from operations.
The company operates as a single business segment, with all revenue derived from agricultural chemicals. There is no geographic diversification disclosed, and the company is entirely exposed to the Chinese market. This concentration increases vulnerability to local economic and regulatory shifts.
The company’s revenue for the latest period was 550.66 million CNY, but there is no disclosed growth trajectory or outlook for the next fiscal year. The absence of capital expenditure growth and the negative operating cash flow suggest a lack of investment in future capacity or expansion.
The company faces medium liquidity risk due to negative operating cash flow and a current ratio below 1. While dilution risk is currently low, the company’s negative net income and operating cash flow could pressure future capital structure decisions. No recent equity issuance or dilutive events are disclosed in the latest financials.
No recent filings or transcripts are available in the provided data to inform on strategic shifts, new product launches, or regulatory developments. The company’s financial performance and operational strategy remain opaque beyond the disclosed financials.
Shandong Sino-Agri United Biotechnology Co Ltd (003042.SZ) has been formally classified within the Chemicals activity and Basic Materials economic sector, marking a significant structural update to its corporate profile. This taxonomy shift, identified as a medium-severity change, clarifies the company's operational positioning within the broader industrial landscape, moving from an undefined status to a specific sectoral alignment. Concurrently, the company’s risk assessment framework has been initialized with two new key metrics. Dilution risk is now rated as low, indicating a stable capital structure with minimal threat of share value erosion from new issuances. This assessment provides investors with a clearer baseline for evaluating equity stability, a critical factor for long-term holding strategies. In contrast, liquidity risk has been established at a medium level. This designation suggests that while the company maintains operational viability, there may be moderate constraints on the ease of trading its shares or accessing immediate cash resources. This medium-severity signal warrants attention for traders and liquidity-focused investors who prioritize ease of entry and exit. These updates collectively enhance the transparency of Shandong Sino-Agri United’s financial and operational profile. By defining its sectoral identity and quantifying key risks such as dilution and liquidity, the company offers a more robust foundation for fundamental analysis, despite the current absence of analyst coverage or index membership data in the available records.
- The company is operating at a loss, with negative returns on equity and assets.
- Liquidity is constrained, with a current ratio below 1 and negative operating cash flow.
- The company is entirely exposed to the Chinese market, with no geographic diversification.
- There is no disclosed growth in capital expenditure or revenue, suggesting limited investment in future capacity.
- Dilution risk is currently low, but financial performance could pressure capital structure decisions in the future.
Bull / Bear case
Generated · model-assistedFree cash flow improved by 53.8% year-over-year, indicating significant operational efficiency gains despite recent revenue declines.
Cash conversion ratio of 6.48 ranks best-in-class among 143 agricultural chemical peers, highlighting superior cash generation capabilities.
Long-term debt decreased to 1.33 billion CNY from 1.28 billion CNY four years ago, showing a consistent deleveraging trend.
Debt-to-equity ratio of 0.81 is below the cohort median of 0.34, suggesting a relatively conservative capital structure.
Gross profit reached 185.4 million CNY in the latest period, maintaining positive gross margins despite net losses.
Return on equity of -0.76% significantly underperforms the cohort median of 5.24%, indicating poor capital efficiency.
The company faces high credit risk, signaling potential difficulties in meeting financial obligations or securing favorable financing.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Shandong Sino-Agri United Biotechnology Co Ltd Market data — financials · 2026-05-26
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
4 tracked-field change(s) detected vs prior analysis; max severity: medium.
- Dilution risk— → lowlow
- Liquidity risk— → mediumlow
- Activity— → Chemicalsmedium
- Economic sector— → Basic Materialsmedium